English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [896]
News [1746]
Articles [213]
Editorials [5]
Conferences [126]
elearning [18]
Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
Research finds correlation between biomarker HSD3B1 and resistance to combined hormone therapy and radiotherapy
ASTRO issues patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast cancer and DCIS
ASTRO issues patient-centered clinical guideline on partial breast irradiation for early-stage invasive breast...
Breast cancer survivors: New training to treat 'chemo-brain'
Breast cancer survivors: New training to treat 'chemo-brain'
ESMO 2023: Lung cancer treatment research enters a new era
ESMO 2023: Lung cancer treatment research enters a new era
Researchers develop innovative technique for distinguishing tumour from normal tissue
Researchers develop innovative technique for distinguishing tumour from normal tissue
PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
PET imaging validates use of common cholesterol drug to enhance HER2-targeted cancer therapy
From prevention to treatment: new hope for genomics in the global fight against cancer
From prevention to treatment: new hope for genomics in the global fight against cancer
Advanced assistive technology for predicting organ deformation during radiotherapy utilising image information
Advanced assistive technology for predicting organ deformation during radiotherapy utilising image information
NCTN trial comparing OS after photon versus proton chemoradiotherapy for patients with inoperable stage II-IIIB NSCLC has met its accrual target
NCTN trial comparing OS after photon versus proton chemoradiotherapy for patients with inoperable stage II-IIIB...
Potential genetic screening for aggressive melanoma
Potential genetic screening for aggressive melanoma
<1...1617181920...175>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top